Home NDC 50090-6237 PIFELTRO
Product NDC 50090-6237
11-digit product format 500906237
Labeler code 50090
Product ID 50090-6237_bcf61557-ab36-4f94-b83c-9024c0cdb968
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name doravirine
Dosage form TABLET, FILM COATED
Route ORAL
Labeler A-S Medication Solutions
Application NDA210806
Marketing category NDA
Marketing start 2018-07-20
Marketing end 0000-00-00
Substance DORAVIRINE
Active strength 100 mg/1
Pharmacologic classes Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N210806-001 PIFELTRO DORAVIRINE 100MG TABLET / ORAL RLD, RS 2018-08-30
Orange Book patents# Current patent rows page 1 of 1 · 3 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N210806-001 8486975 2032-08-30 U-2394 Drug substance, Drug product 2018-09-17 N210806-001 8486975 2032-08-30 U-2630 Drug substance, Drug product 2018-09-17 N210806-001 8486975 2032-08-30 U-3308 Drug substance, Drug product 2018-09-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 N210806-001 PIFELTRO 100MG TABLET / ORAL RLD, RS 2018-08-30 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-01 22:54:32 2026-06 N210806-001 8486975 2032-08-30 U-2630 Drug substance, Drug product 2018-09-17 a50c72e98297…2026-08-01 22:54:32 2026-06 N210806-001 8486975 2032-08-30 U-2394 Drug substance, Drug product 2018-09-17 a50c72e98297…2026-08-01 22:54:32 2026-06 N210806-001 8486975 2032-08-30 U-3308 Drug substance, Drug product 2018-09-17 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 50090-6237-0 50090623700 30 TABLET, FILM COATED in 1 BOTTLE (50090-6237-0) 2022-11-21 0000-00-00 No No Current